Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 2, 1998, Pages 221-230

  Szabó, Gábor ^b   Bátkai, Sándor ^a   Bährle, Susanne ^b   Dengler, Thomas J ^b   Vahl, Christian F ^b   Zimmermann, Rainer ^b   Hagl, Siegfried ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Department of Cardiac Surgery ^*

Author keywords

Adrenergic receptor; Ischemia reperfusion; Nitric oxide; Rat heart; Transplantation

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DOBUTAMINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; ARGININE; CORONARY CIRCULATION; DIASTOLE; DOBUTAMINE; ENZYME INHIBITORS; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED LEW; RECEPTORS, ADRENERGIC, BETA; SYSTOLE; TRANSPLANTATION, HETEROTOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 0344301926     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199802000-00007     Document Type: Article

References (68)

1. Heck CF, Shumway SJ, Kaye MP. The registry report of the International Society of Heart Transplantation: sixth official report -1989. J Heart Transplant 1989;8:271-6.
2. Darracott-Cancovich S, Stovin PGI, Wheeldon D, Wallwork J, Wells F, English TAH. Effect of donor heart damage on survival after transplantation. Eur J Cardiothorac Surg 1989;3:525-32.
3. Kloner RA, Ganotte CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1469-508.
4. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor from the canine vascular endothelium. J Physiol 1985;364:45-56.
5. Jennings RB, Reimer KA, Steenbergen C. Myocardial ischemia revisited: the osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 1986;18:769-80.
6. Cocks TM, Angus JA, Campbell GR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol 1985;123:310-20.
7. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575-80.
8. Schulz R, Smith JA, Lewis MJ, Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol 1991; 104:21-4.
9. Kelm M, Schrader J. Control of coronary tone by nitric oxide. Circ Res 1990;66:1561-75.
10. Pohl U, Lamontagne D. Impaired tissue perfusion after inhibition of endothelium derived nitric oxide. Basic Res Cardiol 1991;86 (suppl 2):97-105.
11. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-34.
12. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994;74:376-82.
13. Hasebe N, Shen Y, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 1993;88:2862-71.
14. Williams MW, Taft CS, Ramnauth S, Zhao ZQ, Vinten-Johansen J. Endogenous nitric oxide (NO) protects against ischemia-reperfusion injury in the rabbit. Cardivasc Res 1995;30:79-86.
15. Amrani M, Chester AH, Jakyakumar CJ, Schyns CJ, Yacoub MH. L-Arginine reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc Res 1995;30:200-4.
16. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-88.
17. Lefer DJ, Nakanishi K, Vinten-Johansen J. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1993;22:S34-43.
18. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res 1995;30:432-9.
19. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.
20. Patel VC, Yellon DM, Singh KJ, Neild GH, Woolfson RG. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 1993;194:234-8.
21. Aukland K, Bower BF, Berliner RW. Measurement of local blood flow with hydrogen gas. Circ Res 1964;14:164-87.
22. Hamano K, Ohmi M, Esato K, Mohri H. Myocardial tissue blood flow in allotransplanted rat heart with a special reference to acute rejection. J Heart Transplant 1989;8:48-52.
23. Aronson CE, Serlick ER. Effects of prolonged perfusion time on the isolated perfused rat heart. Toxicol Appl Pharmacol 1976; 38:479-88.
24. Galinanes M, Lawson CS, Ferrari R, Limb GA, Derias NW, Hearse DJ. Early and late effects of leukopenic reperfusion on the recovery of cardiac contractile function. Circulation 1993;88:673-83.
25. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-9.
26. Galinanes M, Hearse DJ. Metabolic, functional and histologic characterization of the heterotopically transplanted rat heart when used as a model for study of long term recovery from global ischemia. J Heart Lung Transplant 1991;10:79-91.
27. Gregg DE. Regulation of the collateral and coronary circulation of the heart. In: McMichael J, ed. Circulation: proceedings of the Harvey Tercentenary Congress. Oxford, UK: Blackwell, 1958; 163-86.
28. Hagl S, Neuhaus KL, Hinglais JR, Mayr N, Meisner H, Sebening F. The influence of coronary perfusion pressure on the pressure-volume relationship and contractility of the left ventricle. Thoraxchir Vask Chir 1974;22:300-10.
29. Furchgott RF. Role of endothelium in response of vascular smooth muscle. Circ Res 1983;53:557-73.
30. Amezcua JL, Palmer RMJ, De Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1990;97:1119-24.
31. Hiramatsu T, Forbess JM, Miura T, Mayer JE. Effects of L-arginine and L-nitro-arginine-methyl ester on recovery of neonatal lamb hearts after cold ischemia J Thorac Cardiovasc Surg 1995;109:81-7.
32. Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991;19:244-52.
33. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
34. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
35. Bath PMW, MacGregor GA. Spontaneous nitric oxide donors inhibit monocyte chemotaxis and increase intracellular cGMP concentration [Abstract]. J Vasc Res 1992;29:170.
36. Moilanen E, Vuorinen P, Kankaareranta H, Metsaketala T, Vapaatalo H. NO donors inhibit human neutrophil activation in vivo [Abstract]. J Vasc Res 1992;29:170.
37. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide Circulation 1993;88:2451-4.
38. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993; 72:403-12.
39. Engelman DT, Watanabe M, Maulik N, et al. L-Arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg 1995;60:1275-81.
40. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 1986;320:454-6.
41. Rubanyi GM, Vanhoutte PM. Superoxide anions and hypoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-7.
42. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker-Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produces by human leukocytes. Biochem Biophys Res Commun 1991;181:1392-7.
43. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992;260:668-75.
44. Mueller AR, Platz KP, Langehr JM, et al. The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion. Transplantation 1994;58:1309-16.
45. G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 1995;27:419-26.
46. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265:H176-82.
47. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 1993;90:347-51.
48. Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Synthesis of nitric oxide from terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moncada S, Higgs EA, eds. Nitric oxide from L.-ARGININE: a bioregulatory system. Amsterdam: Experta Medica 1990:189-224.
49. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990;87:1620-4.
50. Pabla R, Buda AJ, Flynn DM, Salzberg DB, Lefer DJ. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 1995;269: H1113-21.
51. Szabó G, Bährle S, Dengler TJ, Bátkai S, Vahl CF, Hagl S. Reduction of reperfusion injury after heart transplantation by the nitric oxide donor L-arginine. Langebecks Arch Chir I Forumband 1997;114:7-10.
52. Pabla R, Curtis MJ. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. J Mol Cell Cardiol 1996;28:211-21.
53. Pabla R, Buda AJ, Flynn DM, et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 1996;78:65-72.
54. Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684-91.
55. Takeuchi K, McGowan FX, Danh HC, Glynn P, Simplaceanu E, del Nido PJ. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to the myocardium. J Mol Cell Cardiol 1995;27: 1405-14.
56. Ursell PC, Mayes M. Anatomic distribution of nitric oxide synthase in the heart. Int J Cardiol 1995;50:217-23.
57. 2+-dependent nitric oxide synthase activity after ischemia and reperfusion in the heart. J Cardiovasc Pharmacol 1997;29:291-6.
58. Depré C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995;92:1911-8.
59. Hare JM, Keaney JF Jr, Kelly RA, Loscalzo J, Smith TW, Colucci WS. Inhibition of nitric oxide synthase potentiates the positive inotropic response to β-adrenergic stimulation in normal dogs [Abstract]. Circulation 1993;88(suppl 1):I-1905.
60. Hare JM, Loh MD, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92: 2198-203.
61. Parent R, Al-Obaidi M, Lavallée M. Nitric oxide formation contributes to β-adrenergic dilatation of resistance coronary vessels in conscious dogs. Circ Res 1993;73:241-51.
62. Graves J, Poston L. β-Adrenoreceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993;108:631-7.
63. Rubanyi G, Vanhoutte PM. Endothelium-removal decreases relaxations of canine coronary arteries caused by adrenergic agonists and adenosine. J Cardiovasc Pharmacol 1985;7:139-44.
64. Gray DW, Marshall I. Isoprenaline relaxation of rat thoracic aorta is endothelium-dependent, releases nitric oxide and raises cyclic GMP and cyclic AMP. Br J Pharmacol 1991;102:125P.
65. G-nitro-L-arginine methyl ester on vasodilatator responses to acetylcholine, 5′-N-ethylcarboxyaminoadenosine or salbutamol in conscious rats. Br J Pharmacol 1991;103:1725-32.
66. Kamata K, Miyata H, Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses to isoproterenol in native and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 1989;249:890-4.
67. G-Nitroarginine (L-NOARG), a novel L-arginine reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 1990;99:408-12.
68. 1-adrenergic action. Comp Biochem Physiol 1990;97C:311-5.